Mark Christopher Capone, Chief Operating Officer, MGL at MYRIAD GENETICS INC (MYGN), sold 21,893 shares at $85.40 ($1.9M) on 2009-02-09, disclosed to the SEC on 2009-02-11.
Open-market sale of $1.9M MYGN by Chief Operating Officer, MGL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.40 | 6,081 | $519K | 27.8% |
| 2 | $85.40 | 6,750 | $576K | 30.8% |
| 3 | $85.40 | 9,062 | $774K | 41.4% |
| Total | $85.40 avg | 21,893 | $1.9M | 100% |
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |